TP53 and neoplasm: Using additional β1 integrin-deficient tumours that were not profiled by RNA-seq, we performed direct p53 gene sequencing by Sanger method and identified a missense mutation (14%, 1 out of 7 tumours) resulting in Val/Met substitution in exon 6 (Fig. 4i).